Shire Asks Fed. Circ. To Undo Generic's Win In Lialda Suit
Shire PLC on Monday fought to overturn a decision giving Zydus Pharmaceuticals Inc. the green light to bring its generic version of Shire's gastrointestinal drug Lialda to market, telling a Federal...To view the full article, register now.
Already a subscriber? Click here to view full article